about
p53 Stabilization induces cell growth inhibition and affects IGF2 pathway in response to radiotherapy in adrenocortical cancer cellsCalpain-10 Activity Underlies Angiotensin II-Induced Aldosterone Production in an Adrenal Glomerulosa Cell ModelEffect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells.The potassium channel, Kir3.4 participates in angiotensin II-stimulated aldosterone production by a human adrenocortical cell lineAngiotensin II and III metabolism and effects on steroid production in the HAC15 human adrenocortical cell lineMicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinomaEstablishment and characterization of the first pediatric adrenocortical carcinoma xenograft model identifies topotecan as a potential chemotherapeutic agentA role for phospholipase D in angiotensin II-induced protein kinase D activation in adrenal glomerulosa cell modelsInhibition of Human Adrenocortical Cancer Cell Growth by Temozolomide in Vitro and the Role of the MGMT Gene.Development of monoclonal antibodies against human CYP11B1 and CYP11B2.Sodium deficiency regulates rat adrenal zona glomerulosa gene expression.Regulation of aldosterone synthesis and secretion.Methylation Status of Vitamin D Receptor Gene Promoter in Benign and Malignant Adrenal Tumors.5th International ACC Symposium: An Outlook to Current and Future Research on the Biology of Adrenocortical Carcinoma: Diagnostic and Therapeutic Applications.Tissue Expression and Pharmacological In Vitro Analyses of mTOR and SSTR Pathways in Adrenocortical Carcinoma.The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line.The effect of pioglitazone on aldosterone and cortisol production in HAC15 human adrenocortical carcinoma cells.Protein kinase C-induced activin A switches adrenocortical steroidogenesis to aldosterone by suppressing CYP17A1 expression.EZH2 is overexpressed in adrenocortical carcinoma and is associated with disease progression.Establishment of a mouse xenograft model of metastatic adrenocortical carcinoma.VLDL-activated cell signaling pathways that stimulate adrenal cell aldosterone production.Age-dependent Increases in Adrenal Cytochrome b5 and Serum 5-Androstenediol-3-sulfate.A hypothesis-driven approach identifies CDK4 and CDK6 inhibitors as candidate drugs for treatments of adrenocortical carcinomas.Crude extract of Origanum vulgare L. induced cell death and suppressed MAPK and PI3/Akt signaling pathways in SW13 and H295R cell lines.Development of new preclinical models to advance adrenocortical carcinoma research.Effects of combination treatment with sirolimus and mitotane on growth of human adrenocortical carcinoma cells.DNA damage response induced by Etoposide promotes steroidogenesis via GADD45A in cultured adrenal cells.
P2860
Q25323725-337ACCE5-73F2-45AE-9614-605FF27864D0Q28226675-846980C8-43CA-4AF4-AB46-AAB70A71FDBBQ54608557-17E694CF-3D46-4E4A-B7C6-9BF1E8B59D2FQ54808602-E67FA106-F9D0-4094-B984-93129E97CFF4Q54872306-59EC4A2E-988C-441A-AEF6-705EED4A77C9Q54908017-767D62F6-7F58-4548-A16D-AF7B236F4C07Q54908018-2E848EB9-25D5-446A-95EB-11CFEEE14ED5Q54908020-E5A4DCA8-E0C4-459F-9ACF-CA0BEF3FDD2EQ54950577-37A897E4-271A-4952-8A0F-011C3CE97989Q54971076-F6508BEF-64AE-460C-A9C6-0487BE6A9CFA
P1343
Q34428159-4786D2EE-7629-4366-A8E3-42292A359FC3Q35603349-3FA28B83-9CFF-4E5C-A5A0-A4BE6FF43B70Q36134732-28A41F8A-2C90-4B37-9CDD-234FD486777AQ36177385-CEC2CE13-896B-41C0-9171-AFF7174D00A2Q36486125-63403141-05B1-421B-96CB-38B350E14543Q36546760-C560C6B8-765D-485C-9BD2-6F4E7239B1DAQ36745477-090DA96E-E8ED-4297-92D2-8131DA31809FQ36851448-54301B74-5F5F-46C8-BC15-FA066A21DE21Q37502558-DBF846BE-8736-484E-BF6F-43FCF5CBEE61Q37612477-5DEC01E7-CB1E-4537-B08D-BFA95471877FQ37648023-5ACC5CF6-D25C-4DD6-8AC4-02E40DDD25B5Q38221449-63EBD306-FC4D-42FC-842F-1ECDB1458027Q38382378-2F2FCA91-C3BB-4614-AAD5-BBD9D5C597C8Q38668953-F5CF7EE2-89F7-408E-A1F8-039697D997A3Q38713191-1425B776-7C5D-46D7-9AD2-886CCD57C903Q38771103-87580CAB-92DB-4650-A804-554049FD4E3AQ38974109-1FF6A9E4-C584-4D37-9971-8E18D750D6DBQ39117800-E5381634-8B34-41A0-BB6F-B3296EA524FCQ39791179-CCD3C925-EA11-49E7-AB58-3B9F61DC804CQ40053275-ABB6E657-5DF5-4EF9-A4F7-8559FD878E59Q40737068-12B445C0-DF9B-4F76-B4B3-9C72E47937DFQ46971744-741187F2-17D8-4915-B780-71FEBEE55DEAQ47239499-60443B71-0417-4BC9-B8F8-D8F4A09C7B36Q47656877-56147829-A046-41B9-823C-247EF0F5D0F5Q49681867-C2830D49-2452-42E8-BB0A-D423B1CCA36FQ53251508-C9EB5563-41E9-42DB-A5FD-9297A130A33DQ55435193-59B274D9-A2A8-46F9-BCCC-4C099AEA78E0
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Human adrenocortical carcinoma cell lines.
@ast
Human adrenocortical carcinoma cell lines.
@en
Human adrenocortical carcinoma cell lines.
@nl
type
label
Human adrenocortical carcinoma cell lines.
@ast
Human adrenocortical carcinoma cell lines.
@en
Human adrenocortical carcinoma cell lines.
@nl
prefLabel
Human adrenocortical carcinoma cell lines.
@ast
Human adrenocortical carcinoma cell lines.
@en
Human adrenocortical carcinoma cell lines.
@nl
P2860
P4510
P1476
Human adrenocortical carcinoma cell lines.
@en
P2093
William E Rainey
P2860
P356
10.1016/J.MCE.2011.08.041
P577
2011-09-05T00:00:00Z